Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | KIT |
Variant | W557R |
Impact List | missense |
Protein Effect | unknown |
Gene Variant Descriptions | KIT W557R lies within the juxtamembrane domain (exon 11) of the Kit protein (PMID: 15790786). W557R has been identified in the scientific literature (PMID: 37371685, PMID: 37311038, PMID: 26848617) but has not been biochemically characterized and therefore, its effect on Kit protein function is unknown (PubMed, Nov 2024). |
Associated Drug Resistance | |
Category Variants Paths |
KIT mutant KIT exon11 KIT W557R |
Transcript | NM_000222.3 |
gDNA | chr4:g.54727437T>A |
cDNA | c.1669T>A |
Protein | p.W557R |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
XM_017008178 | chr4:g.54727437T>A | c.1669T>A | p.W557R | RefSeq | GRCh38/hg38 |
XM_017008178.1 | chr4:g.54727437T>A | c.1669T>A | p.W557R | RefSeq | GRCh38/hg38 |
NM_001385285.1 | chr4:g.54727437T>A | c.1669T>A | p.W557R | RefSeq | GRCh38/hg38 |
NM_000222.2 | chr4:g.54727437T>A | c.1669T>A | p.W557R | RefSeq | GRCh38/hg38 |
NM_000222 | chr4:g.54727437T>A | c.1669T>A | p.W557R | RefSeq | GRCh38/hg38 |
NM_000222.3 | chr4:g.54727437T>A | c.1669T>A | p.W557R | RefSeq | GRCh38/hg38 |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|---|---|---|---|---|---|---|
KIT W557R | melanoma | predicted - sensitive | Nilotinib | Case Reports/Case Series | Actionable | In a Phase II trial, Tasigna (nilotinib) resulted in an overall response rate of 26.2% (11/41) including a melanoma patient harboring KIT W557R demonstrating a partial response and progression free survival of 35.4 months and overall survival of 35.4 months (PMID: 28327988). | 28327988 |